Cryptococcosis;Cryptococcose

EMC - Maladies Infectieuses

Volumn 1, Issue 1, 2004, Pages 21-37

  Dromer, Françoise ^a   Lortholary, Olivier ^a,b  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

AIDS; Amphotericin B; Azoles; Cryptococcosis; Cryptococcus neoformans; Fungemia; HIV; Immune reconstitution; Intracranial hypertension; Meningoencephalitis

Indexed keywords

EID: 33645748170     PISSN: 1638623X     EISSN: 1638623X     Source Type: Journal    
DOI: 10.1016/j.emcmi.2003.08.001     Document Type: Short Survey

References (97)

1. Abadi J, Nachman S, Kressel AB, Pirofski L-A. Cryptococcosis in children with AIDS. Clin Infect Dis 1999;28:309-313.
2. Abbott KC, Hypolite I, Poropatich RK, Hshieh P, Cruess D, Hawkes CA, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001;3:203-211.
3. Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV infection. Chest 1999;115:734-740.
4. Aberg JA, Price RW, Heeren DM, Bredt B. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J Infect Dis 2002;185:1179-1182.
5. Amornkul PN, Hu DJ, Tansuphasawadikul S, Lee S, Eampokalap B, Likanonsakul S, et al. Human Immunodeficiency Virus Type 1 Subtype and Other Factors Associated with Extrapulmonary Cryptococcosis among Patients in Thailand with AIDS. AIDS Res Hum Retroviruses 2003;19:85-90.
6. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-131.
7. Blanche P, Gombert B, Ginsburg C, Passeron A, Stubel I, Rigolet A, et al. HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand J Infect Dis 1998;30:615-616.
8. Bozzette SA, Larsen RA, Chiu J, Leal MA, Jacobsen J, Rothman P, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:580-584.
9. Bozzette SA, Larsen RA, Chiu J, Leal MA, Tilles JG, Richman DD, et al. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med 1991;115:285-286.
10. Breton G, Seilhean D, Cherin P, Herson S, Benveniste O. Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy. Am J Med 2002;113:155-157.
11. Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 1998;4:71-83.
12. Cameron ML, Bartlett JA, Gallis HA, Waskin HA. Manifestations of pulmonary cryptococcosis in patients with the acquired immunodeficiency syndrome. Rev Infect Dis 1991;13:64-67.
13. Casadevall A, Mukherjee J, Yuan R, Perfect J. Management of injuries caused by Cryptococcus neoformans-contaminated needles. Clin Infect Dis 1994;19:951-953.
14. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002;34:277-284.
15. Chen S, the Australasian Society for Infectious Diseases (Asid) Mycoses Interest Group. Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infection with liposomal amphotericin B. J Antimicrob Chemother 2002;49(suppl1):57-61.
16. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499-508.
17. Cheung MC, Rachlis AR, Shumak SL. A cryptic cause of cryptococcal meningitis. CMAJ 2003;168:451-452.
18. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-799.
19. Cockerell CJ. Human immunodeficiency virus infection and the skin. A crucial interface. Arch Intern Med 1991;151:1295-1303.
20. Currie BP, Freundlich LF, Soto MA, Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol 1993;31:2519-2522.
21. Darras-Joly C, Chevret S, Wolff M, Matheron S, Longuet P, Casalino E, et al. Cryptococcus neoformans infection in France: epidemiologic features and early pronostic parameters for 76 patients who were infected with the human immunodeficiency virus. Clin Infect Dis 1996;23:369-376.
22. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91:267-272.
23. Diamond DM, Bauer M, Daniel BE, Leal MA, Johnson D, Williams BK, et al. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. Antimicrob Agents Chemother 1998;42:528-533.
24. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974;80:176-181.
25. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988;157:624-628.
26. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, et al. Treatment of cryptococcal meningitis with combination amphotericin B and fluocytosine for four as compared with six weeks. N Engl J Med 1987;317:334-341.
27. Dromer F, Aucouturier P, Clauvel JP, Saimot G, Yeni P. Cryptococcus neoformans antibody levels in patients with AIDS. Scand J Infect Dis 1988;20:283-285.
28. Dromer F, Guého E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol 1993;31:359-363.
29. Dromer F, Mathoulin S, Dupont B, Brugière O, Letenneur L, the French Cryptococcosis Study Group. Comparison of amphotericin B and fluconazole efficacy in the treatment of cryptococcosis in HIV-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996;22(suppl2):154-160.
30. Dromer F, Mathoulin-Pélissier M, Fontanet A, Ronin O, Dupont B, Lortholary O. On behalf of the French Cryptococcosis Study Group. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS 2004 (sous presse).
31. Dromer F, Mathoulin S, Dupont B, Laporte A, the French Cryptococcosis Study Group. Epidemiology of cryptococcosis in France: 9-year survey (1985-1993). Clin Infect Dis 1996;23:82-90.
32. Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O, the French Cryptococcosis Study Group. Individual and environmental factors associated with Cryptococcus neoformans serotype D infections in France. Clin Infect Dis 1996;23:91-96.
33. Dupont B, Crewe Brown HH, Westermann K, Martins MD, Rex JH, Lortholary O, et al. Mycoses in AIDS. Med Mycol 2000;38(suppl1):259-267.
34. Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis 1996;23:827-830.
35. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999;37:838-840.
36. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L-A, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001;107: e66.
37. Graybill JR, Sobel J, Saag M, van der Horst C, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000;30:47-54.
38. Gumbo T, Kadzirange G, Mielke J, Gangaido IT, Hakim JG. Cryptococcus neoformans meningoencephalitis in African patients with acquired immunodeficiency syndrome. Pediatr Infect Dis J 2002;21:54-56.
39. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999;179:449-454.
40. Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000;14:1401-1407.
41. Hammerman KJ, Powell KE, Christianson CS, Huggin PM, Larsh HW, Vivas JR, et al. Pulmonary cryptococcosis: clinical form and treatment. Am Rev Respir Dis 1973;108:1116-1123.
42. Henderson DK, Bennett JE, Huber MA. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest 1982;69:1185-1190.
43. Heyderman RS, Gangaidzo IT, Hakim JG, Mielke J, Taziwa A, Musvaire P, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998;26:284-289.
44. Hospenthal DR, Bennett JE. Flucytosine monotherapy for cryptococcosis. Clin Infect Dis 1998;27:260-264.
45. Hull CM, Heitman J. Genetics of Cryptococcus neoformans. Annu Rev Genet 2002;36:557-615.
46. Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 1982;16:22-29.
47. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002;35:E128-33.
48. King MD, Perlino CA, Cinnamon J, Jernigan JA. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 2002;13:724-726.
49. Kontoyiannis DP, Peitsch WK, Reddy BT, Whimbey EE, Han XY, Bodey GP, et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001;32:E145-E150.
50. Kwon-Chung KJ, Bennett JE. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE, editors. Medical mycology. Philadelphia: Lea and Febiger; 1992. p. 397-446.
51. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM. Cryptococcosis: clinical and biological aspects. Med Mycol 2000;38(suppl1):205-213.
52. Larsen RA, Bozzette SA, Jones BE, Haghighat D, Leal MA, Forthal D, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994;19:741-745.
53. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-187.
54. Lortholary O, Dromer F, Mathoulin-Pélissier S, Fitting C, Improvisi L, Cavaillon JM, et al. Immune mediators in cerebrospinal fluid are influenced by meningeal involvement and human immunodeficiency virus serostatus during Cryptococcus neoformans infection. J Infect Dis 2001;183:294-302.
55. Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med Mycol 1999;37:169-174.
56. Lortholary O, Sitbon K, Droz C, Zeller V, Neuville N, Dellamonica P, et al. Discontinuation of maintenance antifungal therapy for cryptococcosis in AIDS patients: results from an observational cohort study in France. Interscience Conference on Antimicrobial Agents and Chemotherapy; 2002. San Diego CA: American Society of Microbiology; 2002.
57. Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr Opin Microbiol 2002;5:359-365.
58. Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 2002;137(5Pt2):435-478.
59. st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy;2001;Chicago, IL, 2001.
60. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. Molecular Typing of IberoAmerican Cryptococcus neoformans Isolates. Emerg Infect Dis 2003;9:189-195.
61. Meyohas MC, Roux P, Bollens D, Chouaid C, Roznbaum W, Meynard JL, et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995;21:628-633.
62. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003;36:789-794.
63. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995;20:611-616.
64. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995;8:515-548.
65. Neuville S, Dromer F, Chretien F, Gray F, Lortholary O. Physiopathologie des méningites à Cryptococcus neoformans. Ann Med Interne 2002;153:323-328.
66. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O, et al. Primary cutaneous cryptococcosis, a distinct clinical entity. Clin Infect Dis 2003;36:337-347.
67. Newton PN, Thai le H, Tip NQ, Short JM, Chierakul W, Rajanuwong A, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002;35:769-772.
68. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-699.
69. Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999;28:629-633.
70. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002;16:837-874.
71. Pitisuttithum P, Tansuphasawadikul S, Simpson AJH, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 2001;43:226-233.
72. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994;18:789-792.
73. Powderly WG, Keath EJ, Sokol-Anderson M, Kitz D, Kobayashi G. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect Dis Clin Pract 1992;1:314-316.
74. Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:793-798.
75. Rambeloarisoa J, Batisse D, Thiebaut JB, Mikol J, Mrejen S, Karmochkine M, et al. Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS. J Infect 2002;44:185-188.
76. Randhawa HS, Paliwal DK. Occurrence and significance of Cryptococcus neoformans in the oropharynx and on the skin of a healthy population. J Clin Microbiol 1977;6:325-327.
77. Rex JH, Larsen RA, Dismukes WE, Cloud GA, Bennett JE. Catastrophic visual loss due to Cryptococcus neoformans meningitis. Medicine 1993;72:207-224.
78. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-658.
79. Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DM, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999;28:82-92.
80. Rozenbaum R, Rios Gonçalves AJ. Clinical epidemiology study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18:369-380.
81. Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999;28:291-296.
82. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-718.
83. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-89.
84. rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002;81:213-227.
85. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995;21:28-34.
86. Tansuphasawadikul S, Amornkul PN, Tanchanpong C, Limpakarnjanarat K, Kaewkungwal J, Likanonsakul S, et al. Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand. J Acquir Immune Defic Syndr 1999;21:326-332.
87. Temstet A, Roux P, Poirot JL, Ronin O, Dromer F. Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies. J Clin Microbiol 1992;30:2544-2550.
88. Traynor TR, Huffnagle GB. Role of chemokines in fungal infections. Med Mycol 2001;39:41-50.
89. Trevenzoli M, Cattelan AM, Rea F, Sasset L, Semisa M, Lanzafame M, et al. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J Infect 2002;45:173-179.
90. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
91. Van Elden LJ, Walenkamp AM, Lipovsky MM, Reiss P, Meis JF, de Marie S, et al. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS 2000;14:2787-2800.
92. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000;38:407-417.
93. Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant 2002;2:575-580.
94. Visnegarwala F, Graviss EA, Lacke CE, Dural AT, Johnson PC, Atmar RL, et al. Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors. Clin Infect Dis 1998;27:1231-1237.
95. White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 1992;165:960-963.
96. Witt MD, Lewis RJ, Larsen RA, Milefchick EN, Leal MA, Haubrich RH, et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 1996;22:322-328.
97. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986;104:234-240.